The L3.1-405B model provided a good proposal (9.5/10.0) regarding increasing the speed and performance of monoclonal antibody production seen in Table . In specific, AI responses included 4 quotations of original text which were generally correct based on the Kao, M., et al. paper. One exception was the combination of a heading and body of text in the passage "The productions of therapeutic N-linked glycoproteins through glycoengineered plants may exhibit altered biological functions compared with their counterparts bearing WT plant-specific glycans." Meaningful L3.1-405B Part A generation excerpts are shown below, as well as a bioreactor representation in Figure .